Embryo-fetal development (EFD) toxicity evaluation is the second segment of developmental and reproductive toxicology evaluation. With many years of experience in rare disease therapy research and a proven track record of quality, innovation, and customer support, our company provides comprehensive services for embryo-fetal development toxicity evaluation to leading and emerging biopharmaceutical companies and scientific research institutions. Learn more：Embryo-fetal developmental toxicity